The Working Group on strengthening EU manufacturing capacities for critical medicines aims to identify vulnerabilities in the EU critical medicine supply chains and address challenges such as dependence on non-EU manufacturers and production bottlenecks. It endeavours to strengthen the EU's industrial base by increasing local production capabilities and ensuring a stable supply of essential medicines. This effort aims to reduce disruptions and ensure the availability of critical medicines, especially during health emergencies.
